Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06386159
Other study ID # 2023-1178
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 15, 2024
Est. completion date July 30, 2025

Study information

Verified date March 2024
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Xiuqin Feng
Phone 13757119151
Email fengxiuqin@zju.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to establish a practical comprehensive intervention program for dysphagia after extubation in adult ICU patients based on the best evidence of its assessment and intervention, through expert panel discussion and Delphi method. In addition, combining the preliminary experimental results of vagus nerve stimulation applied to PED patients, we further develop a comprehensive intervention program for dysphagia after extubation based on neural regulation mechanism. Finally, the implementation effect of this PED comprehensive intervention program based on neural regulation mechanism will be verified through clinical application.


Recruitment information / eligibility

Status Recruiting
Enrollment 69
Est. completion date July 30, 2025
Est. primary completion date April 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: 1. Patients who met the diagnostic criteria of PED were changed to SSA score =24 2. aged from 18 to 90 years old; 3. oral or nasotracheal intubation for =48 hours; 4. Clear mind 5. Glasgow score =13 points, with good cooperation ability; 6. There was no contraindication to oral feeding after extubation Exclusion Criteria: 1. Other diseases that affect swallowing function (such as stroke, Parkinson's disease, head and neck deformity, radiotherapy after head and neck cancer, burn with inhalation injury, esophageal cancer, chronic obstructive pulmonary disease, etc.); 2. history of reflux and aspiration; 3. tracheotomy; 4. isolation treatment due to respiratory infectious diseases; 5. the presence of implantable electronic devices (e.g., pacemakers, cochlear implants); 6. Traumatic vagus recurrent laryngeal nerve injury, history of vagus nerve surgery, or vagus nerve injury

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Electrical vagus nerve stimulation
Transcutaneous electrical stimulation of the vagus nerve at the lateral neck was performed by rehabilitation therapists. The cervical vagus nerve accompanies the carotid artery and is located at the groove between the trachea and the sternocleidomastoid muscle, which can be located by touching the carotid pulse. The two electrodes were pasted along the path of the cervical vagus nerve.

Locations

Country Name City State
China Feng Xiuqin Hangzhou

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary functional oral intake scale(FOIS) FOIS consists of seven levels: ? Score 1, unable to eat orally at all; ? Score 2, dependent on tube feeding, minimum attempt to eat food or liquid; ? Score 3, dependent on tube feeding, taking single texture food or liquid orally; ? Score 4, completely oral intake of single texture food; ? score 5: fully oral intake of a variety of food textures, but with special preparation or compensation; ?6 points, completely oral feeding without special preparation, but with special food restriction; ?7 points, complete oral feeding without restriction, the higher the score, the better the swallowing function of the patient. In this study, a FOIS score of 6-7 was defined as full oral feeding up to 90 days
Primary standardized Swallowing Assessment(SSA) The first part is the clinical examination.The second part involves observing the patient's ability to swallow 5 mL of water, repeated three times. If there are no abnormalities detected in the above examinations, the amount of water for swallowing is then increased to 60 mL. To obtain the total score, the scores from all three parts are summed up. up to 90 days
Secondary Rate of total oral feeding after the intervention After the intervention, the patient's score on the Functional Oral Intake Scale (FOIS) was between 6 and 7, indicating that the patient has recovered the ability to eat orally. up to 90 days
Secondary Duration of Enteral Nutrition Tube Indwelling The duration of the nasogastric tube or nasointestinal tube indwelling in the patient up to 90 days
Secondary Rate of Re-intubation after Endotracheal Intubation The rate of re-intubation during the intervention period after extubation in patients who have undergone endotracheal intubation up to 90 days
Secondary Incidence of aspiration within one week after extubation Incidence of aspiration within one week after extubation up to 90 days
Secondary The incidence of aspiration pneumonia within one week after extubation The incidence of aspiration pneumonia within one week after extubation up to 90 days
Secondary Inflammation-related indicators: serum C-reactive protein (CRP) Monitoring of patients' inflammatory marker up to 90 days
Secondary Inflammation-related indicators: serum interleukin-6 (IL-6) Monitoring of patients' inflammatory marker up to 90 days
Secondary Inflammation-related indicators: serum procalcitonin, acetylcholine (ACh) Monitoring of patients' inflammatory markers up to 90 days
Secondary Inflammation-related indicators: high mobility group box-1 protein (HMGB1) Monitoring of patients' inflammatory marker up to 90 days
Secondary Days of ICU hospitalization Days of ICU hospitalization up to 90 days
Secondary Total days of hospitalization Total days of hospitalization up to 90 days
Secondary In-hospital survival rate The number of patients who survive during hospitalization up to 90 days
See also
  Status Clinical Trial Phase
Terminated NCT03761823 - Post-extubation Dysphagia